Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.
  • page settings
  • hide sidebar
  • show empty fields
  • layout
  • (too narrow)
  • open all
  • close all
Resources » Paper

Rathaur S et al. (2008) Vaccine "Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis."

  • History

  • Referenced

  • Tree Display

  • My Favorites

  • My Library

  • Comments on Rathaur S et al. (2008) Vaccine "Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis." (0)

  • Overview

    PMID:
    18499308
    DOI:
    10.1016/j.vaccine.2008.03.099
    Status:
    Publication type:
    Journal_article
    WormBase ID:
    WBPaper00054134

    Rathaur S, Yadav M, Gupta S, Anandharaman V, & Reddy MV (2008). Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine, 26, 4094-100. doi:10.1016/j.vaccine.2008.03.099

    Present report enumerates the vaccine potential of a glutathione-S-transferase purified from Setaria cervi against lymphatic filariasis. In jirds (Meriones unguiculatus) vaccination trial, a very significant 82.75% (p<0.005) reduction in adult parasite burden was observed in ScGST immunized group after 90 days post Brugia malayi L3 challenge. An inverse correlation between the antibody level and worm burden was found in ScGST immunized group (Person's correlation r=0.943, p<0.05). No recoveries of worms were obtained in heart and lungs of vaccinated group. The Antibodies reactive to ScGST appeared within four weeks of first dose and were able to neutralize the GST activity up to 86%. In an earlier study we have shown vaccine potential of ScGST against B. malayi by ADCC. Evaluation of cytokine profile in T-cells isolated from BALB/c mice immunized with ScGST were also showed predominance of Th2 response which further maintained the humoral immunity generated by ScGST administration in mice. The overall observations prompted us to envisage ScGST as a potential vaccine candidate against lymphatic filariasis.


    Tip: Seeing your name marked red? Please help us identify you.